Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Sep;162(3):e111-e116.
doi: 10.1016/j.chest.2022.03.052.

A Man With Malaise, Myalgia, and Rapidly Progressive Interstitial Lung Disease

Affiliations
Case Reports

A Man With Malaise, Myalgia, and Rapidly Progressive Interstitial Lung Disease

Marissa O'Callaghan et al. Chest. 2022 Sep.

Abstract

A 45-year-old man sought treatment at the ED during the third wave of the COVID-19 pandemic with a month-long history of fatigue, cough, myalgia, and hand stiffness. He did not report dyspnea. He had no past medical history and previously was fit and active, working as a farmer. He was a lifelong nonsmoker and had no family history of lung disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Posterior anterior chest radiograph demonstrating diffuse alveolar infiltrates bilaterally.
Figure 2
Figure 2
A-D, CT pulmonary angiograms demonstrating diffuse bilateral ground-glass change with reticular nodular opacities opacification in the lower lobes: coronal image (A) and axial slices from lung apices to bases (B-D).
Figure 3
Figure 3
A-C, Photographs showing hyperkeratosis and skin cracking (A, B) and periungual erythema and dilated nail-fold capillaries (C).
Figure 4
Figure 4
A-C, Axial slices from a chest CT scan demonstrating progression of bilateral lower lobe consolidation and bilateral pneumothoraces with extensive subcutaneous emphysema throughout the superficial soft tissues of the chest extending into the mediastinum.
Figure 5
Figure 5
A-C, Photomicrographs of video-assisted thoracoscopic surgery lung biopsy samples showing: (A) cystically dilated subpleural alveoli and rigid-appearing alveolar walls (×125 magnification; scale bar, 1,000 μm), (B) diffuse regular interstitial expansion of alveolar walls by fibrosis consistent with a nonspecific interstitial pneumonia pattern (×100 magnification; scale bar, 100 μm), and (C) focal organizing pneumonia with endoalveolar buds (blue arrows) also present (×100 magnification; scale bar, 100 μm).

References

    1. Sato S., Hirakata M., Kuwana M., et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52(5):1571–1576. - PubMed
    1. Fiorentino D., Chung L., Zwerner J., Rosen A., Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol. 2011;65(1):25–34. - PMC - PubMed
    1. Szodoray P., Hajas A., Kardos L., et al. Distinct phenotypes in mixed connective tissue disease: subgroups and survival. Lupus. 2012;21:1412–1422. - PubMed
    1. Sato S., Kuwana M., Fujita T., Suzuki Y. Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol. 2013;23(3):496–502. - PubMed
    1. Ceribelli A., Fredi M., Taraborelli M., et al. Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis. Clin Exp Rheumatol. 2014;32(6):891–897. - PubMed

Publication types